Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Current Rheumatology Reports
Published in: Current Rheumatology Reports 8/2013

01-08-2013 | SERONEGATIVE ARTHRITIS (MA KHAN, SECTION EDITOR)

Ankylosing Spondylitis: Chinese Perspective, Clinical Phenotypes, and Associated Extra-articular Systemic Features

Authors: Huei-Huang Ho, Ji-Yih Chen

Published in: Current Rheumatology Reports | Issue 8/2013

Login to get access

Abstract

Ankylosing spondylitis (AS) is a common rheumatic disease in the Chinese population, which is the largest population in the world associated with the global burden of health care. Herein we review and report the epidemiology and specific clinical characteristics of Chinese AS. More than 90 % of Chinese AS patients are HLA-B27 positive with the predominant HLA-B*2704 subtype; the incidence of HLA-B27 positivity ranges from 4 to 8 % in the general Chinese population. The first-degree relatives of AS probands often develop atypical AS with relatively mild disease and particularly undifferentiated spondyloarthropathy in females. Chinese AS patients have higher frequencies of juvenile-onset AS and peripheral arthritis. Of extra-articular manifestations, AS patients have earlier onset and more recurrent attacks of HLA-B27-related acute anterior uveitis. Cardiac arrhythmias or other cardiovascular disorders and metabolic syndrome are not infrequently found. Importantly, apical lung diseases in Chinese AS patients are also frequently associated with tuberculosis infection.
Literature
1.
van der Linden SM, van der Heijde D, Maksymowych WP. Ankylosing spondylitis. In: Firestein GS, Budd RC, Harris Jr ED, et al., editors. Kelley’s Textbook of Rheumatology. Philadelphia: Elsevier Saunders Press; 2009. p. 1169–89.CrossRef
2.
•• Ho HH, Yeh SJ, Tsai WP, et al. Paroxysmal supraventricular tachycardia and Wolff–Parkinson–White syndrome in ankylosing spondylitis: a large cohort observation study and literature review. Semin Arthritis Rheum. 2012;42:246–53. This is a recent large cohort clinical study of Chinese patients with AS. Articular, extra-articular features, and pathogenetic associations were described. PubMedCrossRef
3.
4.
Sieper J, Braun J, Rudwaleit M, et al. Ankylosing spondylitis: an overview. Ann Rheum Dis. 2002;61 suppl 3:iii 8–iii 18.
5.
Khan MA. Update on spondyloarthropathies. Ann Inter Med. 2002;136:896–907.CrossRef
6.
Ng SC, Liao Z, Yu DT, et al. Epidemiology of spondyloarthritis in the People’s Republic of China: review of the literature and commentary. Semin Arthritis Rheum. 2007;37:39–47.PubMedCrossRef
7.
Chou CT, Chen JM, Hsu CM, Chen SJ. HLA-B27 and its subtypes in 4 Taiwanese Aborigine tribes: a comparison to Han Chinese patients with ankylosing spondylitis. J Rheumatol. 2003;30:321–5.PubMed
8.
Feltkamp TE, Mardjuadi A, Huang F, Chou CT. Spondyloarthropathies in eastern Asia. Curr Opin Rheumatol. 2001;13:285–90.PubMedCrossRef
9.
Zeng QY. Ankylosing spondylitis in Shantou, China: 15 years’ clinical experience. J Rheumatol. 2003;30:1816–21.PubMed
10.
Chou CT, Pei L, Chang DM, et al. Prevalence of rheumatic diseases in Taiwan: a population study of urban, suburban, rural differences. J Rheumatol. 1994;21:302–6.PubMed
11.
12.
Xiang YJ, Dai SM. Prevalence of rheumatic diseases and disability in China. Rheumatol Int. 2009;29:481–90.PubMedCrossRef
13.
Chou CT. Spondyloarthritis in Asian countries- An overview. Curr Rheumatol Rev. 2008;4:81–6.CrossRef
14.
Nasution AR, Mardjuadi A, Suryadhana NG, et al. Higher relative risk of spondyloarthropathies among B27 positive Indonesian Chinese than native Indonesians. J Rheumatol. 1993;20:988–90.PubMed
15.
Gran JT, Husby G. The epidemiology of ankylosing spondylitis. Semin Arthritis Rheum. 1993;22:319–34.PubMedCrossRef
16.
Ma HJ, Yin QF, Hu FP, et al. Different clinical features in patients with ankylosing spondylitis from southern and northern China. Int J Rheum Dis. 2012;15:154–62.PubMedCrossRef
17.
Wei JC, Tsai WC, Lin HS, et al. HLA-B60 and B61 are strongly associated with ankylosing spondylitis in HLA-B27-negative Taiwan Chinese patients. Rheumatology (Oxford). 2004;43:839–42.CrossRef
18.
Robinson WP, van der Linden SM, Khan MA, et al. HLA-Bw60 increases susceptibility to ankylosing spondylitis in HLA-B27+ patients. Arthritis Rheum. 1989;32:1135–41.PubMedCrossRef
19.
Khan MA. Remarkable Polymorphism of HLA-B27: an Ongoing Saga. Curr Rheumatol Report. 2010;12:337–41.CrossRef
20.
Wei JCC. HLA-B27 subtype in Chinese with ankylosing spondylitis (Posters). J Rheumatol 1998 (suppl 54) 1998; 25:27.
21.
Khan MA. HLA and spondyloarthropathies. In: Mehra N, editor. The HLA Complex in Biology and Medicine. New Delhi, India: Jaypee Brothers Medical Publishers; 2010. p. 422–46.
22.
Gonzalez-Roces S, Alvarez MV, Gonzalez S, et al. HLA-B27 polymorphism and worldwide susceptibility to ankylosing spondylitis. Tissue Antigens. 1997;49:116–22.PubMedCrossRef
23.
Chen IH, Yang KL, Lee A, et al. Low frequency of HLA-B*2706 in Taiwanese patients with ankylosing spondylitis. Eur J Immunogenet. 2002;29:435–8.PubMedCrossRef
24.
van der Linden SM, Valkenburg HA, de Jongh BM, Cats A. The risk of developing ankylosing spondylitis in HLA-B27 positive individuals. A comparison of relatives of spondylitis with the general population. Arthritis Rheum. 1984;27:241–9.PubMedCrossRef
25.
Khan MA, van der Linden SM, Kushner I, et al. Spondylitic disease without evidence of sacroiliitis in relatives of HLA-B27 positive ankylosing spondylitis patients. Arthritis Rheum. 1985;28:40–3.PubMedCrossRef
26.
Chou CT, Lu SJ, Pai L, et al. Family study of ankylosing spondylitis. J Formosan Med Assoc. 1988;87:989–99.
27.
Chou CT, Lin KC, Wei JC, et al. Study of undifferentiated spondyloarthropathy among first-degree relatives of ankylosing spondylitis probands. Rheumatology (Oxford). 2005;44:662–5.CrossRef
28.
Liu Y, Li J, Chen B, et al. Familial aggregation of ankylosing spondylitis in southern China. J Rheumatol. 2001;28:550–3.PubMed
29.
Zhao W, Huang F, Xu M, et al. The expression of monokines and their relation with disease activity in patients with juvenile ankylosing spondylitis. Chin J Rheumatol. 2000 (suppl 1):140.
30.
Zhu J, Lin X, Huang F, et al. Th1/Th2 balances and ankylosing spondylitis. Chin J Rheumatol. 2000;4:202–5.
31.
Chou CT, Uksila J, Toivancn P. Enterobacterial antibodies in Chinese patients with rheumatoid arthritis and ankylosing spondylitis. Clin Exp Rheumatol. 1998;16:161–4.PubMed
32.
Howe HS, Zhao L, Song YW, et al. Seronegative spondyloarthropathy—studies from the Asia Pacific region. Ann Acad Med Singapore. 2007;36:135–41.PubMed
33.
Chen CH, Lin KC, Yu DT, et al. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in ankylosing spondylitis: MMP-3 is a reproducibly sensitive and specific biomarker of disease activity. Rheumatology (Oxford). 2006;45:414–20.CrossRef
34.
Chou CT, Tsai YF, Liu J, et al. The detection of the HLA-B27 antigen by immunomagnetic separation and enzyme-linked immunosorbent assay—comparison with a flow cytometric procedure. J Immunol Methods. 2001;255:15–22.PubMedCrossRef
35.
Chen HA, Chen CH, Lin YJ, et al. Association of bone morphogenetic proteins with spinal fusion in ankylosing spondylitis. J Rheumatol. 2010;37:2126–32.PubMedCrossRef
36.
Chen HA, Chen CH, Liao HT, et al. Clinical, functional, and radiographic differences among juvenile-onset, adult-onset, and late-onset ankylosing spondylitis. J Rheumatol. 2012;15:1013–8.CrossRef
37.
O’Shea FD, Boyle E, Riarh R, et al. Comparison of clinical and radiographic severity of juvenile-onset versus adult-onset ankylosing spondylitis. Ann Rheum Dis. 2009;68:1407–12.PubMedCrossRef
38.
Huang F, Zhang J, Zhu J, et al. Juvenile spondyloarthropathies: the Chinese experience. Rheum Dis Clin North Am. 2003;29:531–47.PubMedCrossRef
39.
Maksymowych WP, Chou CT, Russell AS. Matching prevalence of peripheral arthritis and acute anterior uveitis in individuals with ankylosing spondylitis. Ann Rheum Dis. 1995;54:128–30.PubMedCrossRef
40.
Heuft-Dorenbosch L. vanTubergen A, Spoorenberg A, et al. The influence of peripheral arthritis on disease activity in ankylosing spondylitis patients as measured with the Bath Ankylosing Spondylitis Disease Activity Index. Arthritis Rheum. 2004;51:154–9.PubMedCrossRef
41.
Vander Cruyssen B, Munoz-Gomariz E, Font P, et al. Hip involvement in ankylosing spondylitis: epidemiology and risk factors associated with hip replacement surgery. Rheumatology (Oxford). 2010;49:73–81.CrossRef
42.
Brophy S, Calin A. Ankylosing spondylitis: interaction between genes, joints, age at onset, and disease expression. J Rheumatol. 2001;28:2283–8.PubMed
43.
Lin Z, Gu J, He P, et al. Multicenter validation of BASDAI and BASFI in Chinese ankylosing spondylitis and undifferentiated spondyloarthropathy patients. Rheumatol Int. 2011;31:233–8.PubMedCrossRef
44.
Chen CH, Lin KC, Chen HA, et al. Association of acute anterior uveitis with disease activity, functional ability and physical mobility in patients with ankylosing spondylitis: a cross-sectional study of Chinese patients in Taiwan. Clin Rheumatol. 2007;26:953–7.PubMedCrossRef
45.
Chung YM, Liao HT, Lin KC, et al. Prevalence of spondyloarthropathies in 504 Chinese patients with HLA-B27-associated acute anterior uveitis. Scand J Rheumatol. 2009;38:84–90.PubMedCrossRef
46.
Bulkley BH, Roberts WC. Ankylosing spondylitis and aortic regurgitation. Description of the characteristic cardiovascular lesion from study of eight necropsy patients. Circulation. 1973;48:1014–27.PubMedCrossRef
47.
Bergfeldt L. HLA-B27-associated cardiac disease. Ann Intern Med. 1997;12(8 Pt 1):621–9.CrossRef
48.
49.
Lautermann D, Braun J. Ankylosing spondylitis—Cardiac manifestations. Clin Exp Rheumatol. 2002;20 Suppl 28:S11–5.PubMed
50.
Gould BA, Turner J, Keeling DH, et al. Myocardial dysfunction in ankylosing spondylitis. Ann Rheum Dis. 1992;51:227–32.PubMedCrossRef
51.
Heeneman S, Daemen MJ. Cardiovascular risks in spondyloarthritides. Curr Opin Rheumatol. 2007;19:358–62.PubMedCrossRef
52.
Yildirir A, Aksoyek S, Calguneri M, et al. QT dispersion as a predictor of arrhythmic events in patients with ankylosing spondylitis. Rheumatol (Oxford). 2000;39:875–9.CrossRef
53.
Han C, Robinson Jr DW, Hackett MV, et al. Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol. 2006;33:2167–72.PubMed
54.
Toussirot E, Bahjaoui-Bouhaddi M, Poncet JC, et al. Abnormal autonomic cardiovascular control in ankylosing spondylitis. Ann Rheum Dis. 1999;58:481–7.PubMedCrossRef
55.
Wei JC, Jan MS, Yu CT, et al. Plasma homocysteine status in patients with ankylosing spondylitis. Clin Rheumatol. 2007;26:739–42.PubMedCrossRef
56.
Feltelius N, Hedenström H, Hillerdal G, Hällgren R. Pulmonary involvement in ankylosing spondylitis. Ann Rheum Dis. 1986;45:736–40.PubMedCrossRef
57.
Hamilton KA. Pulmonary disease manifestations of ankylosing spondylitis. Ann Intern Med. 1949;31:216–27.PubMedCrossRef
58.
Rosenow E, Strimlan CV, Muhm JR, Ferguson RH. Pleuropulmonary manifestations of ankylosing spondylitis. Mayo Clin Proc. 1977;52:641–9.PubMed
59.
Hillerdal G. Ankylosing spondylitis lung disease—an underdiagnosed entity? Eur J Respir Dis. 1983;64:437–41.PubMed
60.
Ho HH, Lin MC, Yu KH, et al. Pulmonary tuberculosis and disease-related pulmonary apical fibrosis in ankylosing spondylitis. J Rheumatol. 2009;36:355–60.PubMedCrossRef
61.
Casserly IP, Fenlon HM, Breatnach E, Sant SM. Lung findings on high-resolution computed tomography in idiopathic ankylosing spondylitis—correlation with clinical findings, pulmonary function testing and plain radiography. Br J Rheumatol. 1997;36:677–82.PubMedCrossRef
62.
El Maghraoui A, Chaouir S, Bezza A, et al. Thoracic high resolution computed tomography in patients with ankylosing spondylitis and without respiratory symptoms. Ann Rheum Dis. 2003;62:1856.CrossRef
63.
Lee CC, Lee SH, Chang IJ, et al. Spontaneous pneumothorax associated with ankylosing spondylitis. Rheumatology (Oxford). 2005;44:1538–41.CrossRef
64.
Solak O, Fidan F, Dünder U, et al. The prevalence of obstructive sleep apnoea syndrome in ankylosing spondylitis patients. Rheumatology (Oxford). 2009;48:433–5.CrossRef
65.
Erb N, Karokis D, Demamere JP, et al. Obstructive sleep apnea as a cause of fatigue in ankylosing spondylitis. Ann Rheum Dis. 2003;62:183–4.PubMedCrossRef
66.
Kang JH, Lin HC. Obstructive sleep apnea and the risk of autoimmune diseases: a longitudinal population-based study. Sleep Medicine. 2012;13:583–8.PubMedCrossRef
67.
Malesci D, Niglio A, Mennillo GA, et al. High prevalence of metabolic syndrome in patients with ankylosing spondylitis. Clin Rheumatol. 2007;26:710–4.PubMedCrossRef
68.
van Halm VP, van Denderen JC, Peters MJ, et al. Increased disease activity is associated with a deteriorated lipid profile in patients with ankylosing spondylitis. Ann Rheum Dis. 2006;65:1473–7.PubMedCrossRef
69.
Ho HH, Yu KH, Chen JY, et al. Coexisting ankylosing spondylitis and gouty arthritis. Clin Rheumatol. 2007;26:1655–61.PubMedCrossRef
70.
Beauvais C, Kaplan G, Mougenot B, et al. Cutaneous vasculitis and IgA glomerulonephritis in ankylosing spondylitis. Ann Rheum Dis. 1993;52:61–2.PubMedCrossRef
71.
Lam SM, Ho HH, Dunn P, Luo SF. Association of ankylosing spondylitis with IgA-multiple myeloma: report of a case and pathogenetic considerations. J Formosan Med Assoc. 1989;88:726–8.
72.
O’Neill TW, Harrison BJ, Yin AL, Holt PJ. Ankylosing spondylitis associated with IgA lambda chain myeloma. Br J Rheumatol 1007; 36:401–2.
73.
Borman P, Bodur H, Ak G, et al. The coexistence of Behcet’s disease and ankylosing spondylitis. Rheumatol Int. 2000;19:195–8.PubMedCrossRef
74.
Peluso R, Lupoli GA, Del Puente A, et al. Prevalence of thyroid autoimmunity in patients with spondyloarthropathies. J Rheumatol. 2011;38:1371–7.PubMedCrossRef
75.
Kobak S, Kobak AC, Kabasakal Y, et al. Sjögren’s syndrome in patients with ankylosing spondylitis. Clin Rheumatol. 2007;26:173–5.PubMedCrossRef
76.
Borman P, Ayhan F, Okumus M. Coexistence of rheumatoid arthritis and ankylosing spondylitis. Rheumatol Int. 2010;30:127–9.CrossRef
77.
Brandt J, Maier T, Rudwaleit M, et al. Co-occurrence of spondyloarthropathy and connective tissue disease (MCTD) in a patient with ankylosing spondylitis. Clin Exp Rheumatol. 2002;20:80–4.PubMed
78.
Akkoc N, Sari I, Birlik M, et al. Ankylosing spondylitis and spondyloarthropathy presenting with clinical picture of adult onset Still’s disease: case series. Rheumatology (Oxford). 2008;47:1436–7.CrossRef
79.
Haibel H, Brandt J, Rudwaleit M, et al. Treatment of active ankylosing spondylitis with pamidronate. Rheumatology (Oxford). 2003;42:1018–20.CrossRef
80.
Huang F, Gu J, Zhao W, et al. One-year open-label trial of thalidomide in ankylosing spondylitis. Arthritis Rheum. 2002;47:249–54.PubMedCrossRef
81.
Wei JC, Chan TW, Lin HS, et al. Thalidomide for severe refractory ankylosing spondylitis: a 6-month open-label trial. J Rheumatol. 2003;30:2627–31.PubMed
82.
Deng X, Zhang J, Zhang J, Huang F. Thalidomide reduces recurrence of ankylosing spondylitis in patients following discontinuation of etanercept. Rheumatol Int. 2012; 2012 Nov 11. [Epub ahead of print]
83.
Chou CT. The clinical application of etanercept in Chinese patients with rheumatic diseases. Mod Rheumatol. 2006;16:206–13.PubMedCrossRef
84.
Huang F, Gu J, Zhu P et al. Efficacy and safety of adalimumab in Chinese adults with active ankylosing spondylitis: results of a randomised, controlled trial. Ann Rheum Dis. 2013 Mar 8. [Epub ahead of print]
85.
Bao C, Huang F, Khan MA, et al. Safety and Efficacy of Golimumab in Chinese Patients with Active Ankylosing Spondylitis: 1-Year Results of a Multicenter, Randomized, Double-Blind, Placebo- Controlled Phase III Trial. Submitted for publication.
Metadata
Title
Ankylosing Spondylitis: Chinese Perspective, Clinical Phenotypes, and Associated Extra-articular Systemic Features
Authors
Huei-Huang Ho
Ji-Yih Chen
Publication date
01-08-2013
Publisher
Springer US
Published in
Current Rheumatology Reports / Issue 8/2013
Print ISSN: 1523-3774
Electronic ISSN: 1534-6307
DOI
https://doi.org/10.1007/s11926-013-0344-0

Other articles of this Issue 8/2013

Current Rheumatology Reports 8/2013 Go to the issue

SERONEGATIVE ARTHRITIS (MA KHAN, SECTION EDITOR)

Advances and Challenges in Spondyloarthritis Imaging for Diagnosis and Assessment of Disease

SERONEGATIVE ARTHRITIS (MA KHAN, SECTION EDITOR)

Advances in the Genetics of Spondyloarthritis and Clinical Implications

SERONEGATIVE ARTHRITIS (MA KHAN, SECTION EDITOR)

Spondyloarthritis Associated with Acne Conglobata, Hidradenitis Suppurativa and Dissecting Cellulitis of the Scalp: A Review with Illustrative Cases

OSTEOARTHRITIS (MB GOLDRING, SECTION EDITOR)

Genetically Engineered Mouse Models Reveal the Importance of Proteases as Osteoarthritis Drug Targets

INFLAMMATORY MUSCLE DISEASE (I LUNDBERG, SECTION EDITOR)

Clinical Heterogeneity and Outcomes of Antisynthetase Syndrome

VASCULITIS (LR ESPINOZA, SECTION EDITOR)

IgG4-Associated Vasculitis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits